From the Journals

And the Beat Goes On

November 2025 editorial review highlights several key advances in heart failure care

Share

7 Key Takeaways

  • 1

    20% of heart failure patients have cancer history.

  • 2

    Higher mortality yet similar hospitalization rates for these patients.

  • 3

    Importance of multidisciplinary care emphasized.

  • 4

    Sacubitril/Valsartan shows promise in cardiac dysfunction prevention.

  • 5

    Echo features indicate cardiac wasting in advanced cancer.

  • 6

    High-volume centers linked with lower mortality in cardiogenic shock.

  • 7

    Need for large multicenter trials to confirm findings.

Original Source(s)

And the Beat Goes On

November 2025 editorial review highlights several key advances in heart failure care

  • by Alun Evans

  • January 12, 2026

  • 3 min

Related Content

US Heart Health Progress Stalls

New US cardiovascular statistics document persistent gaps in prevention and treatment across hypertension, diabetes, obesity, and cholesterol management, with marked disparities by age, income, and race.

Beta-Blockers Following MI: Still Needed?

A JAMA Cardiology meta-analysis found no association between long-term beta-blocker therapy and cardiovascular benefit following myocardial infarction in patients with preserved ejection fraction

Marcos A. Nores, M.D., Joins Baptist Health Heart & Vascular Care as Medical Director of Lynn Heart & Vascular Institute

Marcos A. Nores, M.D., board-certified cardiac surgeon, has joined Baptist Health Heart & Vascular Care as medical director of Christine E. Lynn Heart & Vascular Institute at Boca Raton Regional Hospital, part of Baptist Health.

  • by

  • January 5, 2026

  • 4 min